A detailed history of Axiom Investors LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Axiom Investors LLC holds 71,845 shares of TMDX stock, worth $10.9 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
71,845
Previous 83,750 14.21%
Holding current value
$10.9 Million
Previous $6.61 Million 19.64%
% of portfolio
0.05%
Previous 0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$70.86 - $89.93 $843,588 - $1.07 Million
-11,905 Reduced 14.21%
71,845 $5.31 Million
Q4 2023

Feb 12, 2024

BUY
$36.74 - $81.08 $1.4 Million - $3.08 Million
38,029 Added 83.18%
83,750 $6.61 Million
Q3 2023

Nov 13, 2023

BUY
$53.47 - $96.07 $232,113 - $417,039
4,341 Added 10.49%
45,721 $2.5 Million
Q2 2023

Aug 10, 2023

BUY
$66.23 - $88.73 $1.56 Million - $2.09 Million
23,530 Added 131.82%
41,380 $3.48 Million
Q1 2023

May 12, 2023

BUY
$53.63 - $82.33 $957,295 - $1.47 Million
17,850 New
17,850 $1.35 Million

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $4.85B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Axiom Investors LLC Portfolio

Follow Axiom Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axiom Investors LLC , based on Form 13F filings with the SEC.

News

Stay updated on Axiom Investors LLC with notifications on news.